Bayer Cropscience Share Price
Sector: Chemical Manufacturing
5661.50 -24.50 (-0.43%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
5650.00
Today’s High
5726.35
52 Week Low
4220.05
52 Week High
7189.90
5678.30 -14.70 (-0.26%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
5560.00
Today’s High
5731.50
52 Week Low
4217.45
52 Week High
7196.85
Key Metrics
- Market Cap (In Cr) 25437.92
- Beta 0.54
- Div. Yield (%) 2.2
- P/B 8.95
- TTM P/E 38.85
- Sector P/E 17.27
- D/E 0
- Open Price 5685.85
- Prev Close 5686
Bayer Cropscience Analysis
Price Analysis
-
1 Week13.81%
-
3 Months20.07%
-
6 Month-0.25%
-
YTD2.29%
-
1 Year12.72%
Risk Meter
- 37% Low risk
- 37% Moderate risk
- 37% Balanced Risk
- 37% High risk
- 37% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 2
- 2
- 2
- 2
- Hold
- 4
- 3
- 3
- 3
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 7
- 6
- 6
- 6
Bayer Cropscience News
Bayer CropScience shares skyrocket 12% post Q4 Results, dividend announcement
1 min read . 27 May 2025Gillette India, KEC, Vadilal to PTC India: Seven stocks that declared dividend
2 min read . 27 May 2025KEC, PTC India to Gillette India: 5 stocks to declare dividend today
1 min read . 26 May 2025Bayer Cropscience Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 5473.4
- Selling/ General/ Admin Expenses Total
- 449.8
- Depreciation/ Amortization
- 84.9
- Other Operating Expenses Total
- 935.2
- Total Operating Expense
- 4868.7
- Operating Income
- 604.7
- Net Income Before Taxes
- 707.4
- Net Income
- 568
- Diluted Normalized EPS
- 126.38
- Period
- 2025
- Total Assets
- 5245.9
- Total Liabilities
- 2395.5
- Total Equity
- 2850.4
- Tangible Book Valueper Share Common Eq
- 603.89
- Period
- 2025
- Cashfrom Operating Activities
- 262
- Cashfrom Investing Activities
- 85.6
- Cashfrom Financing Activities
- -619.4
- Net Changein Cash
- -271.8
- Period
- 2024
- Total Revenue
- 5103.2
- Selling/ General/ Admin Expenses Total
- 1127.8
- Depreciation/ Amortization
- 73.5
- Other Operating Expenses Total
- 29.7
- Total Operating Expense
- 4211.8
- Operating Income
- 891.4
- Net Income Before Taxes
- 941.4
- Net Income
- 740.5
- Diluted Normalized EPS
- 168.53
- Period
- 2024
- Total Assets
- 4597.1
- Total Liabilities
- 1747.7
- Total Equity
- 2849.4
- Tangible Book Valueper Share Common Eq
- 606.11
- Period
- 2024
- Cashfrom Operating Activities
- 951.6
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- -656.3
- Net Changein Cash
- 295.7
- Period
- 2023
- Total Revenue
- 5139.7
- Selling/ General/ Admin Expenses Total
- 1305.2
- Depreciation/ Amortization
- 79
- Other Operating Expenses Total
- 33.2
- Total Operating Expense
- 4181.3
- Operating Income
- 958.4
- Net Income Before Taxes
- 990.1
- Net Income
- 758.2
- Diluted Normalized EPS
- 150.95
- Period
- 2023
- Total Assets
- 4678.6
- Total Liabilities
- 1966.5
- Total Equity
- 2712.1
- Tangible Book Valueper Share Common Eq
- 577.94
- Period
- 2023
- Cashfrom Operating Activities
- 609.3
- Cashfrom Investing Activities
- 83.3
- Cashfrom Financing Activities
- -613.2
- Net Changein Cash
- 79.4
- Period
- 2022
- Total Revenue
- 4734.4
- Selling/ General/ Admin Expenses Total
- 1187.1
- Depreciation/ Amortization
- 64
- Other Operating Expenses Total
- 25.6
- Total Operating Expense
- 3918.7
- Operating Income
- 815.7
- Net Income Before Taxes
- 846.8
- Net Income
- 645.3
- Diluted Normalized EPS
- 133.87
- Period
- 2022
- Total Assets
- 4352.9
- Total Liabilities
- 1828.6
- Total Equity
- 2524.3
- Tangible Book Valueper Share Common Eq
- 541.81
- Period
- 2022
- Cashfrom Operating Activities
- 215.5
- Cashfrom Investing Activities
- 64.2
- Cashfrom Financing Activities
- -703.3
- Net Changein Cash
- -423.6
- Period
- 2021
- Total Revenue
- 4261.3
- Selling/ General/ Admin Expenses Total
- 942.5
- Depreciation/ Amortization
- 73
- Other Operating Expenses Total
- 18.1
- Total Operating Expense
- 3507.3
- Operating Income
- 754
- Net Income Before Taxes
- 794.5
- Net Income
- 493.1
- Diluted Normalized EPS
- 108.19
- Period
- 2021
- Total Assets
- 4239.3
- Total Liabilities
- 1689
- Total Equity
- 2550.3
- Tangible Book Valueper Share Common Eq
- 551.84
- Period
- 2021
- Cashfrom Operating Activities
- 686.7
- Cashfrom Investing Activities
- 6.7
- Cashfrom Financing Activities
- -555.8
- Net Changein Cash
- 137.6
- Period
- 2020
- Total Revenue
- 3609.4
- Selling/ General/ Admin Expenses Total
- 921.1
- Depreciation/ Amortization
- 64.9
- Other Operating Expenses Total
- 11
- Total Operating Expense
- 3068.3
- Operating Income
- 541.1
- Net Income Before Taxes
- 583.1
- Net Income
- 474.5
- Diluted Normalized EPS
- 127.94
- Period
- 2020
- Total Assets
- 3835.7
- Total Liabilities
- 1263.2
- Total Equity
- 2572.5
- Tangible Book Valueper Share Common Eq
- 560.39
- Period
- 2020
- Cashfrom Operating Activities
- 665.9
- Cashfrom Investing Activities
- -28.9
- Cashfrom Financing Activities
- -148.3
- Net Changein Cash
- 488.7
- Period
- 2019
- Total Revenue
- 3167.3
- Selling/ General/ Admin Expenses Total
- 970.9
- Depreciation/ Amortization
- 43.2
- Other Operating Expenses Total
- 13.5
- Total Operating Expense
- 2710.4
- Operating Income
- 456.9
- Net Income Before Taxes
- 480
- Net Income
- 337.1
- Diluted Normalized EPS
- 99.84
- Period
- 2019
- Total Assets
- 3549.2
- Total Liabilities
- 1309.8
- Total Equity
- 2239.4
- Tangible Book Valueper Share Common Eq
- 639.84
- Period
- 2019
- Cashfrom Operating Activities
- 734.6
- Cashfrom Investing Activities
- -414.7
- Cashfrom Financing Activities
- -158.3
- Net Changein Cash
- 161.6
- Period
- 2025-03-31
- Total Revenue
- 1046.4
- Selling/ General/ Admin Expenses Total
- 111.2
- Depreciation/ Amortization
- 34.3
- Other Operating Expenses Total
- 200.3
- Total Operating Expense
- 909.9
- Operating Income
- 136.5
- Net Income Before Taxes
- 167.9
- Net Income
- 143.3
- Diluted Normalized EPS
- 31.88
- Period
- 2025-03-31
- Total Assets
- 5245.9
- Total Liabilities
- 2395.5
- Total Equity
- 2850.4
- Tangible Book Valueper Share Common Eq
- 603.89
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 262
- Cashfrom Investing Activities
- 85.6
- Cashfrom Financing Activities
- -619.4
- Net Changein Cash
- -271.8
- Period
- 2024-12-31
- Total Revenue
- 1056.9
- Selling/ General/ Admin Expenses Total
- 123.1
- Depreciation/ Amortization
- 15.1
- Other Operating Expenses Total
- 255.8
- Total Operating Expense
- 1052.3
- Operating Income
- 4.6
- Net Income Before Taxes
- 33.6
- Net Income
- 34.2
- Diluted Normalized EPS
- 7.61
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1737.6
- Selling/ General/ Admin Expenses Total
- 115.9
- Depreciation/ Amortization
- 14
- Other Operating Expenses Total
- 246
- Total Operating Expense
- 1567.8
- Operating Income
- 169.8
- Net Income Before Taxes
- 190.1
- Net Income
- 136.3
- Diluted Normalized EPS
- 30.33
- Period
- 2024-09-30
- Total Assets
- 5270.5
- Total Liabilities
- 2188.3
- Total Equity
- 3082.2
- Tangible Book Valueper Share Common Eq
- 656.42
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -85.6
- Cashfrom Investing Activities
- 18.2
- Cashfrom Financing Activities
- -178.9
- Net Changein Cash
- -246.3
- Period
- 2024-06-30
- Total Revenue
- 1631.2
- Selling/ General/ Admin Expenses Total
- 99.6
- Depreciation/ Amortization
- 21.5
- Other Operating Expenses Total
- 233.1
- Total Operating Expense
- 1338.7
- Operating Income
- 292.5
- Net Income Before Taxes
- 315.8
- Net Income
- 254.2
- Diluted Normalized EPS
- 56.56
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 791.5
- Selling/ General/ Admin Expenses Total
- 302.6
- Depreciation/ Amortization
- 15.9
- Total Operating Expense
- 710.8
- Operating Income
- 80.7
- Net Income Before Taxes
- 105.4
- Net Income
- 96
- Diluted Normalized EPS
- 24.5
- Period
- 2024-03-31
- Total Assets
- 4597.1
- Total Liabilities
- 1747.7
- Total Equity
- 2849.4
- Tangible Book Valueper Share Common Eq
- 606.11
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 951.6
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- -656.3
- Net Changein Cash
- 295.7
- Period
- 2023-12-31
- Total Revenue
- 954.9
- Selling/ General/ Admin Expenses Total
- 113.9
- Depreciation/ Amortization
- 15.2
- Other Operating Expenses Total
- 184.7
- Total Operating Expense
- 842.2
- Operating Income
- 112.7
- Net Income Before Taxes
- 124.2
- Net Income
- 93.1
- Diluted Normalized EPS
- 20.72
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Bayer Cropscience Technical
Moving Average
SMA
- 5 Day5439.27
- 10 Day5264.32
- 20 Day4999.02
- 50 Day4910.25
- 100 Day4947.98
- 300 Day5627
Bayer Cropscience Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- 3m India
- 29150
- 315.85
- 1.1
- 41000
- 25714.35
- 32837.68
- Deepak Nitrite
- 2027.75
- -73.1
- -3.48
- 3168.65
- 1780.5
- 27657.1
- Bayer Cropscience
- 5661.5
- -24.5
- -0.43
- 7189.9
- 4220.05
- 25437.92
- Sumitomo Chemical India
- 505.2
- 2.3
- 0.46
- 628
- 427.7
- 25216.84
- Himadri Speciality Chemical
- 470
- -5.95
- -1.25
- 688.5
- 307.3
- 23203.02
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- 3m India
- 69.27
- 17.86
- 20.02
- 10.49
- Deepak Nitrite
- 39.66
- 5.13
- 23.28
- 11.97
- Bayer Cropscience
- 44.93
- 8.95
- 24.01
- 12.97
- Sumitomo Chemical India
- 50.02
- 8.72
- 20.73
- 14.12
- Himadri Speciality Chemical
- 41.96
- 6.27
- 10.85
- 7.27
Bayer Cropscience Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results & Final Dividend
- 11-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Final Dividend
- 01-Feb-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results & Interim Dividend
- 07-Aug-23
- Quarterly Results
- 24-May-23
- Audited Results & Final Dividend
- 07-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 04-Apr-25
- 24-Feb-25
- POM
- 14-Aug-24
- 02-Jul-24
- AGM
- 27-Mar-24
- 23-Feb-24
- POM
- 05-Jan-24
- 30-Nov-23
- POM
- 17-Aug-23
- 04-Jul-23
- AGM
- 22-Mar-22
- 15-Feb-22
- POM
- 12-Aug-21
- 07-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 26-May-25
- -
- -
- 35
- 14-Nov-24
- 28-Nov-24
- 28-Nov-24
- 90
- 23-May-24
- -
- 01-Aug-24
- 35
- 03-Nov-23
- 16-Nov-23
- 16-Nov-23
- 105
- 24-May-23
- -
- 04-Aug-23
- 30
- 09-Nov-22
- 19-Nov-22
- 17-Nov-22
- 100
- 24-May-22
- -
- 04-Aug-22
- 25
- 01-Nov-21
- 13-Nov-21
- 11-Nov-21
- 125
- 25-May-21
- -
- 27-Jul-21
- 25


